Synthesis and characterization of nanocrystalline calcium sulfate for use in osseous regeneration

Yonsei University College of Dentistry, Seodaemun-gu, Seoul, Korea.
Biomedical Materials (Impact Factor: 3.7). 08/2011; 6(5):055007. DOI: 10.1088/1748-6041/6/5/055007
Source: PubMed


Nanoparticles of calcium sulfate (nCS) have potential advantages as a ceramic matrix, scaffold and/or vehicle for delivering growth factors for osseous regeneration in a variety of clinical situations. The objectives of this study were to synthesize and characterize nanoparticles of hemihydrate calcium sulfate (nCS) and to develop a nCS-based system for bone regeneration. A cryo-vacuum method was used to process dihydrate CS into dihydrate nCS, which was then subjected to oven drying to produce hemihydrate. The nCS was sterilized by glow discharge treatment for use as a synthetic graft material for the treatment of bone defects. Electron microscopy showed that the nCS powder consisted of aggregates of closely arranged acicular crystals, approximately 30-80 nm in width, 400-600 nm in length and approximately 80-100 nm in diameter, providing a surface area about ten times that of conventional CS. Thorough physico-chemical characterization confirmed the composition and phase of the material. Cell viability/metabolic activity assays and alkaline phosphate assays confirmed the safety and biocompatibility of nCS. Release kinetics for adsorbed platelet-derived growth factor and bone morphogenetic protein-2 (BMP-2) suggests that nCS may serve as an appropriate vehicle for slow release delivery of these agents. The studies presented here give evidence of the advantages of nCS as a scaffold to support osteoblastic cell activity.


Available from: Mark Swihart
  • Source
    • "nCS was produced according to the method of Park et al [35], [36]. Briefly, a cryo-vacuum process was used to convert calcium sulfate dihydrate microparticles into calcium sulfate dihydrate nanocrystals, then subjected to oven drying to obtain calcium sulfate hemihydrate nanoparticles (nCS) as described previously [37]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Current clinical therapies for critical-sized bone defects (CSBDs) remain far from ideal. Previous studies have demonstrated that engineering bone tissue using mesenchymal stem cells (MSCs) is feasible. However, this approach is not effective for CSBDs due to inadequate vascularization. In our previous study, we have developed an injectable and porous nano calcium sulfate/alginate (nCS/A) scaffold and demonstrated that nCS/A composition is biocompatible and has proper biodegradability for bone regeneration. Here, we hypothesized that the combination of an injectable and porous nCS/A with bone morphogenetic protein 2 (BMP2) gene-modified MSCs and endothelial progenitor cells (EPCs) could significantly enhance vascularized bone regeneration. Our results demonstrated that delivery of MSCs and EPCs with the injectable nCS/A scaffold did not affect cell viability. Moreover, co-culture of BMP2 gene-modified MSCs and EPCs dramatically increased osteoblast differentiation of MSCs and endothelial differentiation of EPCs in vitro. We further tested the multifunctional bone reconstruction system consisting of an injectable and porous nCS/A scaffold (mimicking the nano-calcium matrix of bone) and BMP2 genetically-engineered MSCs and EPCs in a rat critical-sized (8 mm) caviarial bone defect model. Our in vivo results showed that, compared to the groups of nCS/A, nCS/A+MSCs, nCS/A+MSCs+EPCs and nCS/A+BMP2 gene-modified MSCs, the combination of BMP2 gene -modified MSCs and EPCs in nCS/A dramatically increased the new bone and vascular formation. These results demonstrated that EPCs increase new vascular growth, and that BMP2 gene modification for MSCs and EPCs dramatically promotes bone regeneration. This system could ultimately enable clinicians to better reconstruct the craniofacial bone and avoid donor site morbidity for CSBDs.
    PLoS ONE 04/2013; 8(4):e60473. DOI:10.1371/journal.pone.0060473 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Submicron-sized α-calcium sulfate hemihydrate (α-HH) has a promising application in the clinical field. In a reverse microemulsion using n-hexanol as the oil phase, aqueous solution of H2SO4 and CaCl2 as the water phase, and cetyltrimethylammonium bromide (CTAB) as surfactant, α-HH was successfully synthesized in the shape of submicron-rod. α-HH precipitated directly from the microemulsion and either remained metastable or hydrated to calcium sulfate dihydrate (DH) depending on the temperature, H2SO4/CaCl2 molar ratio, and reaction time. The surfactant also played an important role and an increase in the mass ratio of CTAB/water lowered the temperature needed for α-HH precipitation. A higher ratio of CTAB/water and temperature of above 90 °C was a good option for pure α-HH synthesis. After a thorough examination of the synthesis conditions, a reverse microemulsion method was established for the synthesis of α-HH with submicron size.
    Colloids and Surfaces A Physicochemical and Engineering Aspects 09/2012; 409:88–93. DOI:10.1016/j.colsurfa.2012.05.041 · 2.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The repair of craniofacial bone defects is surgically challenging due to the complex anatomical structure of the craniofacial skeleton. Current strategies for bone tissue engineering using a preformed scaffold have not resulted in the expected clinical regeneration due to difficulty in seeding cells into the deep internal space of scaffold, and inability to inject in minimally invasive surgeries. In this study, we used the osteoconductive and mechanical properties of nano-scale calcium sulfate (nCS) and the biocompatibility of alginate to develop the injectable nCS/alginate (nCS/A) paste, and characterized the effect of this nCS/A paste loaded with Bone morphogenetic protein 2 (BMP2) gene modified rat mesenchymal stem cells (MSCs) on bone and blood vessel growth. Our results showed that the nCS/A paste was injectable under small injection forces. The mechanical properties of the nCS/A paste were increased with the increased proportion of alginate. MSCs kept their viability after injection, and MSCs and BMP2 gene-modified MSCs in the injectable pastes remained viable, osteodifferentiated, and yielded high alkaline phosphatase activity. By testing the ability of this injectable paste and BMP2-gene modified MSCs for the repair of critical-sized calvarial bone defects in a rat model, we found that BMP2 gene-modified MSCs in nCS/A (nCS/A+M/B2) showed robust osteogenic activity, which resulted in consistent bone bridging of the bone defects. The vessel density in nCS/A+M/B2 was significantly higher than that in the groups of blank control, nCS/A alone, nCS/A mixed with MSCs (nCS/A+M). These results indicate that BMP2 promotes MSCs mediated bone formation and vascularization in nCS/A paste. Overall, the results demonstrated that the combination of injectable nCS/A paste and BMP2 gene-modified MSCs is a new and effective strategy for the repair of bone defects.
    Tissue Engineering Part A 09/2012; 19(3-4). DOI:10.1089/ten.TEA.2012.0244 · 4.64 Impact Factor
Show more